[1]
Graziani, G. et al. 2024. THE OUTCOME OF INTRAVITREAL BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATMENT: Poster Presentation - Case Report - Resident. Ophthalmologica Indonesiana. 49, S2 (Apr. 2024). DOI:https://doi.org/10.35749/nvxrf729.